De-intensification of basal-bolus insulin regimen after initiation of a GLP-1 RA improves glycaemic control and promotes weight loss in subjects with type 2 diabetes

被引：0
|
作者：
Pierpaolo Falcetta
Francesca Nicolì
Fabrizia Citro
Annamaria Ciccarone
Monia Garofolo
Stefano Del Prato
Cristina Bianchi
机构：
[1] University of Pisa,Department of Clinical and Experimental Medicine
[2] University Hospital of Pisa,Department of Medicine
来源：
Acta Diabetologica | 2023年 / 60卷
关键词：
Insulin therapy; Basal-bolus; Glucagon-like peptide-1 receptor agonist; De-intensification;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：53 / 60
页数：7
相关论文
共 50 条
  • [41] Optimal treatment intensification for glycaemic control in patients with type 2 diabetes on two oral agents: real world comparison of GLP-1, OADs and insulin
    Desouza, C.
    Kirk, A. Ross
    Mangla, K. Kant
    Wolden, M. Lyng
    Lingvay, I.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S286 - S287
  • [42] Challenging the 50-50 rule for the basal-bolus insulin ratio in patients with type 2 diabetes who maintain stable glycaemic control
    Harper, Roy
    Bashan, Eran
    Williams, Kevin J.
    Sritharan, Sajitha
    Willis, Mark
    Marriott, Deanna J.
    Hodish, Israel
    DIABETES OBESITY & METABOLISM, 2023, 25 (02): : 581 - 585
  • [43] Insulin Dosage Adjustments After Initiation of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes
    Chen, Mandy
    Vider, Etty
    Plakogiannis, Roda
    JOURNAL OF PHARMACY PRACTICE, 2022, 35 (04) : 511 - 517
  • [44] Expert Opinion on Optimising Type 2 Diabetes Treatment Using Fixed-Ratio Combination of Basal Insulin and GLP-1 RA for Treatment Intensification and Simplification
    Haluzik, Martin
    Taybani, Zoltan
    Araszkiewicz, Aleksandra
    Cerghizan, Anca
    Mankovsky, Boris
    Zuhdi, Agbaria
    Malecki, Maciej
    DIABETES THERAPY, 2024, 15 (08) : 1673 - 1685
  • [45] Basal insulin initiation on the top of metformin improves glycaemic control and safety in Chinese insulin-naive patients with type 2 diabetes
    Zhang, H.
    Zhang, P.
    Luo, Y.
    Zhu, D.
    Li, X.
    Ji, J.
    Ji, L.
    DIABETOLOGIA, 2018, 61 : S441 - S442
  • [46] Introduction of insulin glulisine in combination with insulin glargine to basal-bolus therapy improves metabolic control in patients with type 1 diabetes in everyday clinical practice
    Ruhnau, Klaus-Juergen
    DIABETES, 2006, 55 : A479 - A479
  • [47] Transferring to insulin detemir basal-bolus therapy improves glycaemic control and reduces hypoglycaemia without weight gain in Type 2 diabetes: comparison of 26-week data from two PREDICTIVE™ studies
    Dornhorst, A.
    Merilainen, M.
    Koenen, C.
    Looij, B-J
    DIABETIC MEDICINE, 2008, 25
  • [48] Introduction of insulin glulisine in combination with insulin glargine to basal-bolus therapy improves metabolic control in patients with type 2 diabetes in everyday clinical practice
    Bernd, Donaubauer
    DIABETES, 2006, 55 : A480 - A480
  • [49] Freestyle libre use in people with type 2 diabetes using basal-bolus insulin is associated with improved glycaemic control: A real-world analysis
    Williams, David M.
    Crockett, Elin
    Aye, Su
    Latheef, Muhammed R.
    Chokor, Mahmoud
    Roberts, Richard
    Bain, Stephen C.
    Stephens, Jeffrey W.
    Min, Thinzar
    PRIMARY CARE DIABETES, 2023, 17 (02) : 202 - 203
  • [50] Feasibility of Simplification From a Basal-Bolus Insulin Regimen to a Fixed-Ratio Formulation of Basal Insulin Plus a GLP-1RA or to Basal Insulin Plus an SGLT2 Inhibitor: BEYOND, a Randomized, Pragmatic Trial
    Giugliano, Dario
    Longo, Miriam
    Caruso, Paola
    Di Fraia, Rosa
    Scappaticcio, Lorenzo
    Gicchino, Maurizio
    Petrizzo, Michela
    Bellastella, Giuseppe
    Maiorino, Maria Ida
    Esposito, Katherine
    DIABETES CARE, 2021, 44 (06) : 1353 - 1360
12345